Sirenia Capital Management LP Discloses New 5.7% Passive Stake in Kodiak Sciences Inc.

On May 15, 2026, Sirenia Capital Management LP and Alex Silverstein filed a Schedule 13G with the SEC, disclosing a new passive ownership stake in Kodiak Sciences Inc. (KOD). The reporting persons disclosed beneficial ownership of 3,495,000 shares of common stock, representing 5.7% of the company's outstanding shares. The shares are held by SILV Fund, Ltd., an investment fund managed by Sirenia Capital Management. Alex Silverstein serves as the managing member of the general partner of Sirenia. The filing indicates that the position was acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The ownership percentage was calculated based on 61,847,870 shares outstanding as of March 19, 2026. This filing marks a significant new institutional position for Sirenia Capital Management in the clinical-stage biopharmaceutical company.